{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:01:44Z","timestamp":1792008104363,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1124\/jpet.116.234930","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T20:50:22Z","timestamp":1487710222000},"page":"322-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Endothelin ETA Receptor Blockade, by Activating ETB Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention"],"prefix":"10.1016","volume":"361","author":[{"given":"Magali","family":"Vercauteren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Trensz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Iglarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Clozel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.116.234930_bib1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1172\/JCI200421064","article-title":"Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention","volume":"114","author":"Ahn","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.234930_bib2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1152\/jappl.1964.19.5.829","article-title":"Plasma and red cell volume after prolonged severe exercise","volume":"19","author":"Astrand","year":"1964","journal-title":"J Appl Physiol"},{"key":"10.1124\/jpet.116.234930_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1164\/rccm.200307-957OC","article-title":"Sitaxsentan therapy for pulmonary arterial hypertension","volume":"169","author":"Barst","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1124\/jpet.116.234930_bib4","first-page":"653","article-title":"Profile of past and current clinical trials involving endothelin receptor antagonists: the novel \"-sentan\" class of drug","volume":"231","author":"Battistini","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1124\/jpet.116.234930_bib5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1524-6175.2007.07244.x","article-title":"Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study","volume":"9","author":"Black","year":"2007","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1124\/jpet.116.234930_bib6","doi-asserted-by":"crossref","first-page":"F1424","DOI":"10.1152\/ajprenal.00015.2010","article-title":"Cooperative role of ETA and ETB receptors in mediating the diuretic response to intramedullary hyperosmotic NaCl infusion","volume":"299","author":"Boesen","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/jpet.116.234930_bib7","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/cncr.22996","article-title":"A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer","volume":"110","author":"Carducci","year":"2007","journal-title":"Cancer"},{"key":"10.1124\/jpet.116.234930_bib8","doi-asserted-by":"crossref","first-page":"L1075","DOI":"10.1152\/ajplung.00251.2005","article-title":"Endothelin-mediated increases in lung VEGF content promote vascular leak in young rats exposed to viral infection and hypoxia","volume":"289","author":"Carpenter","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/jpet.116.234930_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0022-3565(25)22357-6","article-title":"Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist","volume":"270","author":"Clozel","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 3","key":"10.1124\/jpet.116.234930_bib10","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.1097\/00005344-199506263-00079","article-title":"Are there different ETB receptors mediating constriction and relaxation?","volume":"26","author":"Clozel","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/jpet.116.234930_bib11","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1152\/jappl.1994.77.2.1030","article-title":"Evans blue dye in the assessment of permeability-surface area product in perfused rat lungs","volume":"77","author":"Dallal","year":"1994","journal-title":"J Appl Physiol (1985)"},{"key":"10.1124\/jpet.116.234930_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00005344-200307000-00008","article-title":"Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat","volume":"42","author":"Ding","year":"2003","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 1","key":"10.1124\/jpet.116.234930_bib13","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/01.fjc.0000166205.66555.40","article-title":"ETA receptor blockade attenuates hypertension and decreases reactive oxygen species in ETB receptor-deficient rats","volume":"44","author":"Elmarakby","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/jpet.116.234930_bib14","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1476-5381.1996.tb16688.x","article-title":"Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi","volume":"117","author":"Fukuroda","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.116.234930_bib15","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Gali\u00e8","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.116.234930_bib16","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Gali\u00e8","year":"2008","journal-title":"Circulation"},{"key":"10.1124\/jpet.116.234930_bib17","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1172\/JCI8609","article-title":"Salt-sensitive hypertension in endothelin-B receptor-deficient rats","volume":"105","author":"Gariepy","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.234930_bib18","doi-asserted-by":"crossref","first-page":"F1274","DOI":"10.1152\/ajprenal.00190.2006","article-title":"Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention","volume":"291","author":"Ge","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/jpet.116.234930_bib19","doi-asserted-by":"crossref","first-page":"F692","DOI":"10.1152\/ajprenal.00100.2005","article-title":"Collecting duct-specific knockout of the endothelin A receptor alters renal vasopressin responsiveness, but not sodium excretion or blood pressure","volume":"289","author":"Ge","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/jpet.116.234930_bib20","first-page":"73","article-title":"Renal excretory function in conscious Long Evans and vasopressin deficient (Brattleboro) rats after endothelin-A receptor inhibition","volume":"23","author":"Girchev","year":"1998","journal-title":"Acta Physiol Pharmacol Bulg"},{"key":"10.1124\/jpet.116.234930_bib21","doi-asserted-by":"crossref","first-page":"27679","DOI":"10.1074\/jbc.M403601200","article-title":"Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers","volume":"279","author":"Gregan","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.116.234930_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1023\/A:1019822107048","article-title":"Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer","volume":"22","author":"Harada","year":"2002","journal-title":"Cell Mol Neurobiol"},{"key":"10.1124\/jpet.116.234930_bib23","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/00004872-200018120-00015","article-title":"ETA receptor blockade induces fibrosis of the clipped kidney in two-kidney-one-clip renovascular hypertensive rats","volume":"18","author":"Hocher","year":"2000","journal-title":"J Hypertens"},{"key":"10.1124\/jpet.116.234930_bib24","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1124\/jpet.108.142976","article-title":"Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist","volume":"327","author":"Iglarz","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.234930_bib25","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.eururo.2008.11.002","article-title":"Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial","volume":"55","author":"James","year":"2009","journal-title":"Eur Urol"},{"key":"10.1124\/jpet.116.234930_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000107791","article-title":"Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension--a multi-center randomized study","volume":"109","author":"Kaluski","year":"2008","journal-title":"Cardiology"},{"key":"10.1124\/jpet.116.234930_bib27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1124\/jpet.109.157065","article-title":"Inhibition of endothelin ETB receptor system aggravates neointimal hyperplasia after balloon injury of rat carotid artery","volume":"331","author":"Kitada","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.234930_bib28","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0272-6386(97)90004-4","article-title":"Endothelins in the normal and diseased kidney","volume":"29","author":"Kohan","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1124\/jpet.116.234930_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.mnh.0000186852.15889.1a","article-title":"The renal medullary endothelin system in control of sodium and water excretion and systemic blood pressure","volume":"15","author":"Kohan","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1124\/jpet.116.234930_bib30","doi-asserted-by":"crossref","first-page":"H1814","DOI":"10.1152\/ajpheart.00220.2006","article-title":"Paradoxical coronary microcirculatory constriction during ischemia: a synergic function for nitric oxide and endothelin","volume":"291","author":"Kusmic","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.116.234930_bib31","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJM199110033251404","article-title":"Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis","volume":"325","author":"Lerman","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.116.234930_bib32","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/01.CIR.0000038497.80095.E1","article-title":"Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT)","volume":"106","author":"L\u00fcscher","year":"2002","journal-title":"Circulation"},{"key":"10.1124\/jpet.116.234930_bib33","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/01.HYP.21.6.752","article-title":"Potential role of endothelin in hypertension. Controversy on endothelin in hypertension","volume":"21","author":"L\u00fcscher","year":"1993","journal-title":"Hypertension"},{"key":"10.1124\/jpet.116.234930_bib34","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1681\/ASN.2009060593","article-title":"Avosentan for overt diabetic nephropathy","volume":"21","author":"Mann","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/jpet.116.234930_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.HYP.32.1.89","article-title":"Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression","volume":"32","author":"Matsuura","year":"1998","journal-title":"Hypertension"},{"key":"10.1124\/jpet.116.234930_bib36","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/sj.bjp.0701036","article-title":"Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries","volume":"120","author":"Mickley","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.116.234930_bib37","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1210\/en.2004-1590","article-title":"Therapeutic effects of tolvaptan, a potent, selective nonpeptide vasopressin V2 receptor antagonist, in rats with acute and chronic severe hyponatremia","volume":"146","author":"Miyazaki","year":"2005","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.116.234930_bib38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/HYPERTENSIONAHA.108.123687","article-title":"Contribution of endothelin A receptors in endothelin 1-dependent natriuresis in female rats","volume":"53","author":"Nakano","year":"2009","journal-title":"Hypertension"},{"key":"10.1124\/jpet.116.234930_bib39","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/01.HYP.0000161878.81141.62","article-title":"Extrarenal ETB plays a significant role in controlling cardiovascular responses to high dietary sodium in rats","volume":"45","author":"Ohkita","year":"2005","journal-title":"Hypertension"},{"key":"10.1124\/jpet.116.234930_bib40","first-page":"87","article-title":"Transgenic rat models of vasopressin overexpression","volume":"66","author":"Oiso","year":"2003","journal-title":"Nagoya J Med Sci"},{"key":"10.1124\/jpet.116.234930_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1527-3466.2002.tb00082.x","article-title":"BQ-788, a selective endothelin ET(B) receptor antagonist","volume":"20","author":"Okada","year":"2002","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1124\/jpet.116.234930_bib42","doi-asserted-by":"crossref","first-page":"17097","DOI":"10.1074\/jbc.272.27.17097","article-title":"Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion","volume":"272","author":"Pedram","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.116.234930_bib43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/01.HYP.0000158262.11935.d0","article-title":"Endothelin, angiotensin, and oxidative stress in hypertension","volume":"45","author":"Pollock","year":"2005","journal-title":"Hypertension"},{"key":"10.1124\/jpet.116.234930_bib44","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.116.234930_bib45","doi-asserted-by":"crossref","first-page":"E535","DOI":"10.1152\/ajpendo.00344.2003","article-title":"Regulation of vasopressin secretion by ETA and ETB receptors in compartmentalized rat hypothalamo-neurohypophysial explants","volume":"286","author":"Rossi","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1124\/jpet.116.234930_bib46","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.116.234930_bib47","first-page":"546","article-title":"[Endothelin receptors in bovine retinal vessels--quantitative receptor autographic analysis with radioluminography]","volume":"99","author":"Sato","year":"1995","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"10.1124\/jpet.116.234930_bib48","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1159\/000102534","article-title":"Endothelin-1-induced pulmonary vasoreactivity is regulated by ET(A) and ET(B) receptor interactions","volume":"44","author":"Sauvageau","year":"2007","journal-title":"J Vasc Res"},{"key":"10.1124\/jpet.116.234930_bib49","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/jcph.152","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of macitentan, an endothelin receptor antagonist, in an ascending multiple-dose study in healthy subjects","volume":"53","author":"Sidharta","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1124\/jpet.116.234930_bib50","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/clpt.2009.15","article-title":"Dose-dependent acute and sustained renal effects of the endothelin receptor antagonist avosentan in healthy subjects","volume":"85","author":"Smolander","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.116.234930_bib51","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/jpet.113.205286","article-title":"Myocardial, smooth muscle, nephron, and collecting duct gene targeting reveals the organ sites of endothelin A receptor antagonist fluid retention","volume":"346","author":"Stuart","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.116.234930_bib52","first-page":"F690","article-title":"Effects of ET-1 on water and chloride transport in cortical collecting ducts of the rat","volume":"264","author":"Tomita","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1124\/jpet.116.234930_bib53","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/01.CIR.97.8.752","article-title":"Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade","volume":"97","author":"Verhaar","year":"1998","journal-title":"Circulation"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524195481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524195481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.116.234930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:54:41Z","timestamp":1739962481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524195481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0022356524195481"],"URL":"https:\/\/doi.org\/10.1124\/jpet.116.234930","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelin ETA Receptor Blockade, by Activating ETB Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.116.234930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}